Novel production method for chitin and chitosan
Genetically modified microorganisms with activated cell-wall integrity and inactivated calcineurin pathways efficiently convert chitin to chitosan within cells and secrete it, addressing the environmental and quality issues of traditional extraction methods.
Patent Information
- Application Number
- JP2023082603
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-18
- Publication Date
- 2024-11-28
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Current methods for producing chitin and chitosan from crustacean sources or fungal cell walls require harsh chemicals and high temperatures, leading to environmental impact and difficulty in achieving uniform, high-quality products.
A method involving genetically modified microorganisms with activated cell-wall integrity pathways and inactivated calcineurin pathways, enabling intracellular conversion of chitin to chitosan and secretion into the medium, using genes such as Smi1, Crh1, and Cda1 to enhance chitin production and conversion.
This approach allows for stable, environmentally friendly production of chitin and chitosan with reduced environmental impact by secreting chitosan into the medium, overcoming the limitations of traditional extraction methods.
Smart Images

Figure 2024165970000001 
Figure 2024165970000002 
Figure 2024165970000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an efficient method for producing chitin and chitosan using microorganisms, particularly metabolically engineered microorganisms. [Background technology]
[0002] Chitin is a natural polymer consisting of a linear copolymer of β-(l-4) linked N-acetylglucosamine and glucosamine. Chitin is also useful as a raw material for preparing glucosamine and chitosan. Unlike chitin, chitosan is water soluble and has numerous nutritional, medical, pharmaceutical and industrial applications. Currently, chitin is mainly extracted from raw materials such as shrimp and crab shells. Chitosan is commercially produced from chitin by hydrolysis with strong alkali at high temperatures for long periods of time. Commercial processes are limited by raw material supplies. It is also difficult to provide a uniform, high-quality product when starting from shellfish materials.
[0003] Being natural ingredients, chitin and chitosan are highly compatible with the body and completely meet all the requirements for functional foods. They are also highly regarded as multifunctional substances with great value in a wide range of fields, including the medical field (artificial skin, surgical sutures, artificial dialysis membranes, various medical support products, etc.), the industrial field (textiles, cosmetics, daily necessities, wastewater treatment, photographic film, dyes, papermaking, biodegradable plastics, etc.), the agricultural field (soil conditioners, fertilizers, non-polluting pesticides, feed, etc.), radioactive contamination removal, liquid crystals, ion exchange membranes, etc.
[0004] Conventionally, chitosan has been produced by treating chitin contained in crustaceans, mushrooms, etc. with strong alkali or strong acid, but this method has a large environmental impact because it uses strong alkali or strong acid. A technology has been devised to use the cell walls of fungi and other microorganisms as an alternative source of chitin and chitosan to replace crustaceans (Patent Document 1). However, the microscopic walls of fungi have a layered structure, and chitin and chitosan exist deep inside, so it was necessary to destroy the cell walls in order to extract them. Therefore, even when using the cell walls of microorganisms as an alternative source, harsh conditions such as strong alkali or strong acid, high temperature, and long processing times were required.
[0005] Patent documents 2 and 3 disclose techniques relating to a method for producing chitin / chitosan using microorganisms such as yeast. However, there is no mention of secreting chitin / chitosan into a medium or recovering chitin / chitosan from the medium. Patent documents 4 and 5 disclose methods for producing proteins using budding yeast (Saccharomyces cerevisiae), but there is no mention of producing chitin or chitosan. In particular, in Patent document 5, chitin / chitosan is not secreted outside the cells. [Prior art documents] [Patent documents]
[0006] [Patent Document 1] Special Publication No. 2005-529191 [Patent Document 2] Japanese Patent Application Publication No. 8-103271 [Patent Document 3] International Publication No. 2004 / 092391 [Patent Document 4] Korean Patent Application Publication No. 1996 / 0023035 [Patent Document 5] International Publication No. 2009 / 144358 Summary of the Invention [Problem to be solved by the invention]
[0007] The objective of the present invention is to provide a method for efficiently recovering chitin and chitosan from microorganisms. [Means for solving the problem]
[0008] As a result of intensive research into the above-mentioned problems, the present inventors have found that by modifying a microorganism so that the cell-wall integrity pathway (hereinafter also referred to as the CWI pathway) is activated and the calcineurin pathway (hereinafter also referred to as the CN pathway) is inactivated, and preferably further modifying the microorganism so that chitin can be converted to chitosan within the cell, the amount of chitin and chitosan secreted (produced) outside the cell is improved compared to the conventional method. In addition, the present inventors have found genes and combinations thereof suitable for modification, and have further researched based on these findings, thereby completing the present invention. That is, the present invention is as follows.
[0009] [1] A modified microorganism that produces chitin, comprising: The microorganism is characterized in that, as a result of the modification, the cell-wall integrity pathway (CWI pathway) is activated and the calcineurin pathway (CN pathway) is inactivated, compared to an unmodified microorganism. [2] The microorganism described in [1], further comprising a functional deficiency of at least one cell wall synthesis gene. [3] The microorganism described in [1] or [2], further comprising a functional deficiency of at least one cell wall integrity maintaining gene. [4] The microorganism described in any one of [1] to [3], wherein the modification is a functional deficiency of the Smi1 gene in the microorganism. [5] The microorganism described in any one of [2] to [4], wherein the cell wall synthesis gene is selected from the group consisting of a chitin transglycosylase gene and a β-glucan synthase gene. [6] The microorganism described in [3], wherein the cell wall integrity maintaining gene is selected from the group consisting of a cell wall protein gene and a membrane protein gene. [7] The microorganism according to any one of [1] to [6], further modified so as to convert chitin into chitosan intracellularly. [8] The microorganism described in [7], wherein the modification that enables conversion of chitin to chitosan within the cells is achieved by introducing a chitin deacetylase gene. [9] The microorganism described in any one of [1] to [8], wherein the microorganism is a yeast.
[10] The microorganism described in [9], wherein the yeast is Saccharomyces cerevisiae.
[11] A method for producing chitin / chitosan using a microorganism capable of producing chitin, comprising: A method for producing chitin / chitosan, which includes modifying the microorganism so that the cell-wall integrity pathway (CWI pathway) is activated and the calcineurin pathway (CN pathway) is inactivated compared to an unmodified microorganism.
[12] The method of
[11] , further comprising functionally deleting at least one cell wall synthesis gene.
[13] The method of production described in
[11] or
[12] , further comprising functionally deleting at least one cell wall integrity maintaining gene.
[14] The method according to any one of
[11] to
[13] , wherein the modification comprises rendering the Smi1 gene in the microorganism functionally defective.
[15] The method according to
[12] , wherein the cell wall synthesis gene is selected from the group consisting of a chitin transglycosylase gene and a β-glucan synthase gene.
[16] The method according to any one of
[13] to
[15] , wherein the cell wall integrity maintaining gene is selected from the group consisting of a cell wall protein gene and a membrane protein gene.
[17] The method according to any one of
[11] to
[16] , further comprising modifying the cells so that chitin can be converted into chitosan within the cells.
[18] The method according to
[17] , wherein the modification capable of converting chitin into chitosan within the cells is achieved by introducing a chitin deacetylase gene.
[19] The method according to any one of
[11] to
[18] , wherein the microorganism is yeast.
[20] The method according to
[19] , wherein the yeast is Saccharomyces cerevisiae.
[21] The production method described in
[17] , which comprises culturing a microorganism in a medium containing a carbon source and secreting chitin / chitosan into the medium.
[22] The method according to
[21] , wherein the carbon source is glucose. Effect of the Invention
[0010] According to the present invention, it is possible to produce chitin and chitosan using microorganisms. In particular, by converting glucose into chitosan through an enzymatic reaction within the cells and secreting and producing it, stable production with little environmental impact is possible. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] The present invention will now be described. Terms used in the present specification have the meanings commonly used in the art unless otherwise specified. 1. Microorganisms of the Present Invention (Modified Microorganisms of the Present Invention) The present invention relates to 1. A modified microorganism that produces chitin, comprising: The present invention provides a microorganism characterized in that, as a result of the modification, the cell-wall integrity pathway (CWI pathway) is activated and the calcineurin pathway (CN pathway) is inactivated, as compared to an unmodified microorganism. The modified microorganism (hereinafter also referred to as "modified microorganism of the present invention") is not particularly limited as long as it has the above-mentioned characteristics, but is preferably a fungus, more preferably a filamentous fungus or yeast that contains a large amount of chitin in the cell wall. In cases where the cell wall does not normally contain chitin or contains only a small amount of chitin, it can be modified in advance by genetic manipulation to produce chitin, and these can also be preferably used in the present invention. Examples of filamentous fungi include the genus Aspergillus, the genus Penicillium (e.g., Penicillium chrysogenum), the genus Trichoderma, the genus Cephalosporium, the genus Acremonium, the genus Neurospora, the genus Botrytis, the genus Cochliobolus, the genus Monascus, etc. Among these, the genus Aspergillus, the genus Botrytis, and the genus Cochliobolus are more preferred, and the genus Aspergillus is more preferred. Examples of filamentous fungi belonging to the genus Aspergillus that can be used in the present invention include Aspergillus oryzae, Aspergillus sojae, Aspergillus nidulans / Emericella nidulans, Aspergillus niger, Aspergillus fumigatus, etc., with Aspergillus oryzae, Aspergillus sojae, Aspergillus nidulans, or Aspergillus niger being preferred, Aspergillus oryzae and Aspergillus sojae being more preferred, and Aspergillus oryzae being more preferred. Examples of filamentous fungi of the genus Botrytis that can be used in the present invention include Botrytis cinerea (teleomorph: Botryotinia fuckeliana), Botrytis alli, Botrytis scamosa, Botrytis bysoisia, etc. Examples of filamentous fungi of the genus Cochliobolus that can be used in the present invention include Cochliobolus heterostrophus (anamorph: Bipolaris maydis), Cochliobolus carbonum, Cochliobolus miavianus, Cochliobolus victoria, etc. Examples of fungi of the genus Monascus include Monascus purpureus (red koji mold), Monascus ruber, Monascus pilosus, etc. As the yeast, any known yeast may be used, and is not particularly limited. Examples of such yeast include yeasts of the genus Saccharomyces such as Saccharomyces cerevisiae, the genus Schizosaccharomyces such as Shizosaccharomyces pombe, the genus Candida such as Candida lipolytica, the genus Torulaspora such as Torulaspora delbrueckii, the genus Kluyveromyces such as Kluyveromyces thermotolerans, and the genus Pichia membranaefaciens. membranaefaciens and the like, and yeasts belonging to the genus Pichia are preferred, yeasts belonging to the genus Saccharomyces or Schizosaccharomyces are preferred, and yeasts belonging to the genus Saccharomyces are most preferred. Further examples of useful species include Saccharomyces cerevisiae, Shizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces fragilis, Kluyveromyces phaffii, Pichia membranaefaciens, Pichia acaciae, Pichia inositovora, Pichia anomala, Pichia farinosa, Pichia sorbitophila, Pichia pastoris, Pichia etchergei, and the like. etchellsii, Debaryomyces roberchiae, Debaryomyces hansenii, Candida lipolytica, Candida albicans, Candida pseudotropicalis, Candida stellata, Candida utilis, Yarrowia lipolytica, Hansenula polymorpha, etc., but are not limited thereto. Most preferred is Saccharomyces cerevisiae or Schizosaccharomyces pombe. The most preferred modified microorganisms are Saccharomyces cerevisiae, Schizosaccharomyces pombe, and Aspergillus oryzae. These strains are commercially available or can be obtained and prepared based on known literature. For example, in ATCC, a registration number corresponding to each strain is assigned, and the strain can be obtained by using this registration number (see http: / / www.atcc.org / ). The registration number corresponding to each strain is described in the ATCC catalog. As Saccharomyces cerevisiae, specifically, BY4741 strain (ATCC4040002), S288C strain (ATCC26108), and YPH499 (ATCC204679) can be used. As Schizosaccharomyces pombe, specifically, ATCC38366, ATCC38399, and ATCC38436 can be used. As Aspergillus oryzae, specifically, ATCC42149, ATCC1011, ATCC10124, and ATCC14895 can be used. As Candida utilis, specifically, the ATCC22023 strain can be used. Particularly preferred is Saccharomyces cerevisiae.
[0012] Here, the term "modified microorganism" refers to a microorganism in which the biological activity of the wild type or unmodified microorganism is enhanced or reduced (including complete loss of activity) compared to the wild type or unmodified microorganism (unmodified microorganism). Modified microorganisms are created by "modifying" a microorganism. The "modification" of a microorganism is not particularly limited as long as the biological activity is enhanced or reduced (including complete loss of activity) compared to the microorganism before modification. Specific examples include genetic modification of the microorganism and the application of various stresses to the microorganism. The genetic modification is not particularly limited and known techniques can be appropriately adopted. Specific examples of genetic modification are gene mutations caused by substitution, deletion, insertion and / or addition of bases in a gene, and the mutations can enhance / increase or suppress / reduce the function or expression of the gene. As an example, a modified microorganism is a microorganism in which the function of the gene is lost due to a genetic mutation. Various stresses that induce the modification of a microorganism are not particularly limited and known ones can be used. In the case of the present invention, the stress is a stress that activates the CWI pathway and induces the inactivation of the CN pathway. For example, it is known that the CWI pathway is activated by heat shock stress and cell wall stress (e.g., surfactants, alcohol, substances related to osmotic pressure changes).
[0013] "The function or expression of a gene is enhanced / increased" specifically means that the expression level of the gene per cell is increased compared to that of an unmodified microorganism, and the function of the gene is enhanced accordingly. "The expression of a gene is increased" may more specifically mean that the transcription level (mRNA level) of the gene is increased and / or the translation level (protein level) of the gene is increased. The expression of the gene may be increased, for example, 1.1-fold, 1.2-fold, 1.3-fold, 1.4-fold, 1.5-fold, 1.6-fold, 1.7-fold, 1.8-fold, 1.9-fold, 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, or 10-fold compared to that of an unmodified microorganism. "The function or expression of a gene is suppressed / reduced" specifically means that the expression level of the gene per cell is decreased compared to that of an unmodified strain, and the function of the gene is reduced accordingly. "Decreased gene expression" may more specifically mean a decrease in the amount of gene transcription (amount of mRNA) and / or a decrease in the amount of gene translation (amount of protein). "Decreased gene expression" includes cases where the gene is not expressed at all. Such cases are also referred to as functional deficiency of the gene. The expression of the gene may be reduced to, for example, 50% or less, 20% or less, 10% or less, 5% or less, or 0% of that of an unmodified microorganism.
[0014] As shown in the examples below, the chitin-producing modified microorganisms of the present invention are genetically modified to activate the CWI pathway and inactivate the CN pathway compared to unmodified microorganisms, and it is preferable that the modification is a reduction in expression of a specific gene, particularly a functional deficiency.
[0015] The reduction in gene expression may be due to, for example, a reduction in transcription efficiency, a reduction in translation efficiency, or a combination thereof. The reduction in gene expression can be achieved, for example, by modifying an expression regulatory sequence such as a gene promoter, a Shine-Dalgarno (SD) sequence (also called a ribosome binding site (RBS)), or a spacer region between the RBS and the start codon. When modifying an expression regulatory sequence, the expression regulatory sequence is modified preferably by one or more bases, more preferably two or more bases, and particularly preferably three or more bases. The reduction in gene transcription efficiency can be achieved, for example, by replacing a promoter of a gene on a chromosome with a weaker promoter. The term "weaker promoter" refers to a promoter that weakens the transcription of a gene compared to the wild-type promoter that is originally present. An example of a weaker promoter is an inducible promoter. That is, an inducible promoter can function as a weaker promoter under non-inducing conditions (for example, in the absence of an inducer). In addition, a part or all of the expression regulatory sequence may be deleted. In addition, the reduction in gene expression can also be achieved, for example, by manipulating factors involved in expression control. Factors involved in expression control include small molecules (inducers, inhibitors, etc.), proteins (transcription factors, etc.), and nucleic acids (siRNA, etc.) involved in transcription and translation control. Reduction of gene expression can also be achieved, for example, by introducing a mutation into the coding region of the gene that reduces the expression of the gene. For example, gene expression can be reduced by replacing a codon in the coding region of the gene with a synonymous codon that is used less frequently in the host. Furthermore, gene expression itself can be reduced, for example, by disrupting the gene as described below.
[0016] "A gene is disrupted" means that the gene is modified so that it does not produce a protein that functions normally. "Not producing a protein that functions normally" includes cases where no protein is produced from the gene, and cases where a protein is produced from the gene with reduced or lost function (activity or properties) per molecule.
[0017] The destruction of a gene can be achieved, for example, by deleting (deleting) the gene on a chromosome. "Deletion of a gene" refers to the deletion of a part or the whole region of the coding region of a gene. Furthermore, the whole gene may be deleted, including the sequences before and after the coding region of the gene on a chromosome. The region to be deleted may be any region, such as the N-terminal region (the region coding the N-terminal side of a protein), an internal region, or a C-terminal region (the region coding the C-terminal side of a protein), as long as the activity of the protein can be reduced. In general, the longer the region to be deleted, the more reliably the gene can be inactivated. The region to be deleted may be, for example, a region with a length of 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, or 95% or more of the entire length of the coding region of the gene. In addition, it is preferable that the sequences before and after the region to be deleted do not match in reading frame. A mismatch in reading frame may cause a frameshift downstream of the region to be deleted.
[0018] Gene disruption can also be achieved, for example, by introducing an amino acid substitution (missense mutation) into the coding region of a gene encoding a target protein on a chromosome, by introducing a stop codon (nonsense mutation), or by introducing a frameshift mutation that adds or deletes 1 to 2 bases. Gene disruption can also be achieved, for example, by inserting another sequence into the coding region of a gene encoding a target protein on a chromosome (Journal of Biological Chemistry 272:8611-8617(1997), Proceedings of the National Academy of Sciences, USA 95 5511-5515(1998), Journal of Biological Chemistry 26 116, 20833-20839(1991)).
[0019] Gene disruption can also be achieved, for example, by inserting another base sequence into the coding region of the gene on the chromosome. The insertion site may be any region of the gene, but the longer the base sequence to be inserted, the more reliably the gene can be inactivated. In addition, it is preferable that the sequences before and after the insertion site do not have the same reading frame. A mismatch in the reading frame may cause a frameshift downstream of the insertion site. The other base sequence is not particularly limited as long as it reduces or eliminates the activity of the encoded protein, and examples of such sequences include marker genes such as antibiotic resistance genes and genes useful for producing target substances.
[0020] The gene may be disrupted so that the amino acid sequence of the encoded protein is deleted (defective). In other words, modification to reduce the activity of the protein can be achieved, for example, by deleting the amino acid sequence of the protein (a part or all of the region of the amino acid sequence), specifically by modifying the gene so as to code a protein from which the amino acid sequence (a part or all of the region of the amino acid sequence) is deleted. The term "deletion of the amino acid sequence of the protein" refers to the deletion of a part or all of the region of the amino acid sequence of the protein. The term "deletion of the amino acid sequence of the protein" refers to the absence of the original amino acid sequence in the protein, and also includes the case where the original amino acid sequence is changed to another amino acid sequence. That is, for example, a region that has been changed to another amino acid sequence by frameshift may be considered as the deleted region. The deletion of the amino acid sequence typically shortens the full length of the protein, but there may be cases where the full length of the protein does not change or is extended. For example, the deletion of a part or all of the region of the coding region of the gene can delete the region coded by the deleted region in the amino acid sequence of the encoded protein. For example, the introduction of a stop codon into the coding region of a gene can delete the region coded by the region downstream of the introduction site in the amino acid sequence of the encoded protein. For example, the introduction of a frameshift in the coding region of a gene can delete the region coded by the frameshift site.
[0021] The above-mentioned modification of a gene on a chromosome can be achieved, for example, by preparing a mutant gene modified so that it does not produce a protein that functions normally, transforming a host with recombinant DNA containing the mutant gene, and causing homologous recombination between the mutant gene and a wild-type gene on the chromosome, thereby replacing the wild-type gene on the chromosome with the mutant gene. In this case, the recombinant DNA can be easily manipulated if it contains a marker gene according to the host's characteristics such as nutritional requirements. Examples of mutant genes include genes in which a part or all of the coding region of a gene has been deleted, genes in which a missense mutation has been introduced, genes in which a nonsense mutation has been introduced, genes in which a frameshift mutation has been introduced, and genes in which an insertion sequence such as a transposon or a marker gene has been introduced. Even if a protein encoded by a mutant gene is produced, it has a three-dimensional structure different from that of the wild-type protein, and its function is reduced or lost.
[0022] Furthermore, gene modification to reduce protein activity may be performed, for example, by mutation treatment, such as irradiation with X-rays, ultraviolet light, and treatment with mutagens such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), ethyl methanesulfonate (EMS), and methyl methanesulfonate (MMS).
[0023] The above-mentioned gene modification techniques may be used alone or in any combination.
[0024] The reduction in expression or function of the gene due to genetic modification can be confirmed by measuring the expression level at both the gene level and the protein level encoded by the gene.
[0025] The reduction in the biological activity of the target protein can be confirmed by measuring the biological activity. In another embodiment, the reduction in the biological activity of the target protein can be confirmed by confirming an increase or decrease in the transcription amount of the gene encoding the target protein, or an increase or decrease in the amount of the target protein.
[0026] The reduction in the transcription amount of a gene encoding a protein of interest can be confirmed by comparing the amount of mRNA transcribed from the gene with that of a non-modified strain. Methods for evaluating the amount of mRNA include northern hybridization and RT-PCR (Molecular cloning (Cold Spring Harbor Laboratory Press, Cold Spring Harbor (USA), 2001)). When the transcription amount is reduced, it is preferable that the amount of mRNA is reduced to, for example, 50% or less, 30% or less, 20% or less, 10% or less, 5% or less, or 0% compared to the non-modified strain.
[0027] The reduction in the amount of the target protein can be confirmed by Western blotting using an antibody (Molecular cloning (Cold Spring Harbor Laboratory Press, Cold Spring Harbor (USA), 2001)). When the amount of the target protein is reduced, the amount is preferably reduced to, for example, 50% or less, 30% or less, 20% or less, 10% or less, 5% or less, or 0% compared to the non-modified strain.
[0028] When the entire gene encoding the protein is deleted (disrupted) as a modification to reduce biological activity (including complete loss of biological activity), this is preferable because it is simple and reliable since it is only necessary to confirm the expression status of the gene.
[0029] Cell walls are structures found in plant, fungal, and bacterial cells, but not in animal cells. The cell walls of microorganisms, especially fungi, are constructed with multilayer structures mainly composed of polysaccharides, which exist as skeletal polysaccharides such as chitin, cellulose, or (1,3)-β-glucan, and matrix such as mannan. In the biosynthesis of cell walls, β-glucan, the main component of cell walls, is synthesized by β-glucan synthases (Fks1, Fks2) using UDP-glucose as a substrate. Chitin, which is important for maintaining the strength of the cell wall, is synthesized by chitin synthases (Chs1, Chs2, Chs3) using UDP-GlcNAc as a substrate. Chitin synthesized by chitin synthase is cross-linked to β-glucan by chitin transglycosylases Crh1, Crh2, and Crr1, contributing to the complexity and robustness of the mesh structure of the cell wall. Factors that contribute to the robustness of the cell wall include cell wall proteins such as Cwp and membrane proteins such as Pun1. It is known that reducing the function of these proteins in yeast reduces stress resistance against drugs and other stresses. Cell wall remodeling in response to external stress is regulated by the cell wall integrity pathway (CWI pathway) and the calcineurin pathway (CN pathway), which are conserved signaling cascades that maintain cell wall homeostasis. The CWI and CN pathways regulate the expression of genes involved in the cell cycle and the synthesis of various cell wall components and their precursors.
[0030] Cell wall integrity pathway (CWI pathway) The cell wall integrity pathway refers to the major signaling pathway that controls de novo cell wall synthesis in wall-bearing microorganisms (eg, fungi). The CWI pathway is responsible for cell cycle-dependent cell wall synthesis and responses to environmental stresses (cell wall stress) such as cell growth, temperature, and low osmolarity. These signals are transmitted into the cell, activating Rho1, which then transmits information to the downstream signal cascade. The signal cascade of the CWI pathway is composed of protein kinase C Pkc1, MAPKKK Bck1, MAPKK Mkk1 / Mkk2, and MAPK Slt2. Activation of this cascade activates downstream transcription factors such as Rlm1, which further leads to activation of cell wall synthesis genes. Therefore, an example of activation of the CWI pathway is activation of Slt2, which is located downstream of the cascade. Activation of the CWI pathway promotes phosphorylation of Slt2 by the MAPKK Mkk / Mkk2, i.e., Slt2 is activated. Activation of the CWI pathway can be confirmed by activation of Slt2 = increase in the phosphorylation level of Slt2.
[0031] Calcineurin pathway (CN pathway) Calcineurin is a Ca receptor that is highly conserved from yeast to mammals. 2+ / calmodulin-dependent protein phosphatase. In yeast, when the CN pathway is activated by various cell membrane stresses such as high osmolarity and high temperature, it dephosphorylates and activates the transcription factor Crz1 protein, inducing the expression of genes controlled by Crz1 (e.g., genes that maintain cell wall integrity). Therefore, inactivation of Crz1, which is located downstream of the cascade, can be used as an example of inactivation of the CN pathway. Inactivation of the CN pathway inhibits the dephosphorylation of Crz1 by CN, i.e., inactivates Crz1. Inactivation of the CN pathway can be confirmed by inactivation of Crz1 = inhibition of dephosphorylation of Crz1 = increased phosphorylation level of Crz1.
[0032] The modified microorganism of the present invention is characterized in that the CWI pathway is activated and the CN pathway is inactivated, compared to unmodified microorganisms. The activation of the CWI pathway and / or the inactivation of the CN pathway are not particularly limited, as long as the function or expression of genes belonging to the CWI pathway and / or the CN pathway in the modified microorganism is enhanced or suppressed compared to unmodified microorganisms, and is effective for the production and secretion of chitin. In one embodiment of the present invention, Smi1 (also known as Knr4) is an example of a gene whose function is deleted, compared to unmodified microorganisms, to activate the CWI pathway and inactivate the CN pathway. The deletion of the function of the Smi1 gene is a preferred embodiment of the present invention. Smi1 is thought to be a gene involved in (1,3)-β-glucan synthesis by regulating the synthesis of cell wall glucan and chitin. In the modified microorganism of the present invention, factors that directly or indirectly interact with Smi1 and contribute to the activation of the CWI pathway and / or the inactivation of the CN pathway are also preferred as targets for modification (mutation). Examples of such factors include Slt2, Rlm1, and Crz1.
[0033] In the present invention, in addition to the modification in which the CWI pathway is activated and the CN pathway is inactivated, it is preferable to further have a functional deficiency of at least one cell wall synthesis gene and / or cell wall integrity maintenance gene.
[0034] Cell wall synthesis genes Examples of cell wall synthesis genes, particularly in the case of fungi that contain chitin as a major constituent, include the chitin transglycosylase gene, β-glucan synthase gene, and chitin biosynthesis-related genes, with the chitin transglycosylase gene and β-glucan synthase gene being preferred. Chitin transglycosylase includes Crh1, Crh2 (also known as UTR2), and Crr1, with Crh1 being preferred. Chitin transglycosylase functions to transfer β(1→6) and β(1→3) glucans from the cell wall to chitin (transglycosylation). Examples of the β-glucan synthase gene include Fks1 and Fks2. Chitin biosynthesis-related genes include Gfa1, Chs1, Chs2, and Chs3.
[0035] Cell wall integrity maintenance genes Examples of genes for maintaining cell wall integrity include cell wall protein genes and membrane protein genes. An example of the cell wall protein gene is a cell wall mannoprotein gene. Mannoproteins are proteins (polypeptide chains) to which mannose is bound as a modified sugar, and different types of mannoproteins are present on the surface of yeast cell walls. Examples of cell wall mannoproteins include Cwp2 and Cwp1, with Cwp2 being preferred. Cwp2 functions as a GPI-anchored protein. Pun1 (also known as YLR414c) is a membrane protein involved in maintaining cell wall integrity. Pun1 is a stress-responsive protein involved in cell wall integrity and is regulated by signal transduction pathways such as the CN pathway, which depend on the cause of cellular stress. In particular, it has been suggested that it is regulated by the transcription factor Crz1, which belongs to the CN pathway.
[0036] Modified microorganisms suitable for use in the present invention are preferably genetic mutant strains of yeast, characterized in that the CWI pathway is activated and the CN pathway is inactivated compared to unmodified microorganisms, and further have a functional deficiency of at least one cell wall synthesis gene and / or at least one cell wall integrity maintenance gene. The modified microorganism of the present invention is preferably a yeast, more preferably a mutant strain of Saccharomyces cerevisiae. Compared with the unmodified microorganism (wild strain) Saccharomyces cerevisiae BY4741, the modified microorganism of the present invention has a significantly activated CWI pathway and a significantly inactivated CN pathway. In a preferred embodiment, the significant activation of the CWI pathway includes activation of Slt2, specifically a significant increase in the phosphorylation level of Slt2. In a preferred embodiment, the significant activation of the CN pathway includes inactivation of Crz1, specifically a significant increase in the phosphorylation level of Crz1.
[0037] "Significant increase in phosphorylation level" means that the amount of each phosphorylated protein is significantly increased compared to that of a wild-type strain or an unmodified microorganism, and preferably the amount of the phosphorylated protein may be increased by 1.1-fold, 1.2-fold, 1.3-fold, 1.4-fold, 1.5-fold, 1.6-fold, 1.7-fold, 1.8-fold, 1.9-fold, 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold, or 10-fold.
[0038] In view of the objective of the present invention, which is to efficiently recover chitin / chitosan from microorganisms, it is preferable that the modified microorganism of the present invention is modified so that chitin can be converted to chitosan intracellularly. Such modifications preferably include the introduction of chitin deacetylase genes (Cda1, Cda2, Cda3, etc.).
[0039] 2. Manufacturing method of chitin and chitosan (the manufacturing method of the present invention) The present invention provides a method for producing chitin / chitosan using a microorganism capable of producing chitin, The present invention also provides a method (hereinafter also referred to as the production method of the present invention), which includes modifying the microorganism so that the CWI pathway is activated and the CN pathway is inactivated compared to an unmodified microorganism. In the production method of the present invention, it is preferable to further modify the microorganism so that at least one cell wall synthesis gene and / or at least one cell wall integrity maintenance gene are functionally deleted. The definition of each term and preferred embodiments thereof are the same as those described above in the section "1. Microorganisms of the present invention." In the production method of the present invention, chitin / chitosan can be prepared from a microbial culture obtained by culturing the microorganism of the present invention, preferably yeast. As described later in the Examples, in the production method of the present invention, chitin / chitosan is secreted into the medium, and chitin / chitosan can be collected from the culture supernatant. The method of culturing the microorganism of the present invention will be described below using the case where the microorganism is yeast as an example.
[0040] The medium for culturing the microorganism of the present invention is appropriately selected depending on the type of microorganism used. Either synthetic or natural medium can be used as long as it contains a carbon source, a nitrogen source, inorganic substances, and small amounts of micronutrients as necessary. Any type of carbon source and nitrogen source can be used in the medium as long as it is available to the microorganism used. As the carbon source, various carbohydrates such as glucose, glycerol, fructose, sucrose, maltose, mannose, starch, starch hydrolysate, and molasses can be used. As the nitrogen source, various inorganic and organic ammonium salts such as ammonia, ammonium chloride, ammonium sulfate, ammonium carbonate, and ammonium acetate, or natural organic nitrogen sources such as meat extract, yeast extract, corn steep liquor, casein hydrolysate, fish meal or its digested product, and defatted soybean meal or its digested product can be used. In many cases, natural organic nitrogen sources can be both nitrogen and carbon sources. As inorganic substances, potassium monohydrogen phosphate, potassium dihydrogen phosphate, potassium chloride, magnesium sulfate, sodium chloride, ferrous sulfate, and the like can be used as necessary.
[0041] The culture is carried out under aerobic conditions such as shaking culture or submerged culture with aeration and stirring. The culture temperature is preferably in the range of 20 to 50°C, and particularly preferably in the range of 28 to 37°C. The pH of the medium during culture may be appropriately adjusted depending on the growth of the microorganism, and may be, for example, pH 5 to 7. The culture time is usually 12 hours to 10 days, more preferably 24 hours to 8 days, and further preferably 36 hours to 6 days.
[0042] Chitin and chitosan are recovered from the culture containing the microorganisms obtained as described above. The microorganisms of the present invention use glucose, which is a carbon source in the medium, to convert chitin to chitosan through an enzymatic reaction within the cells. Since the cell wall structure of the microorganisms of the present invention has been impaired by genetic modification, chitin and the chitosan converted from it are secreted outside the cells. Therefore, chitin and chitosan can be obtained not only from cells that contain chitin and chitosan within the cells, but also from the culture medium in which the cells are cultured (the cells and the culture medium are also referred to as cell culture). Chitin and chitosan do not necessarily need to be isolated and purified as long as their biological activity is maintained. Chitin and chitosan can be recovered from cell cultures by various purification and separation techniques commonly used in the field, such as centrifugation, concentration, and filtration. Specifically, a microorganism that produces chitin and chitosan, such as Saccharomyces cerevisiae, is cultured in an appropriate liquid medium, and a fraction containing chitin and chitosan is separated and recovered from the resulting culture. If chitin and chitosan are present in the intracellular (cytoplasmic) fraction, the culture is centrifuged to recover the cells, which are then disrupted by ultrasonication, lysozyme treatment, osmotic shock treatment, or the like, and centrifuged to obtain the supernatant. If chitin and chitosan are present in the medium, the solid components of chitin and chitosan can be recovered directly by concentrating the culture supernatant as is or with a filter such as ultrafiltration. Alternatively, chitin and chitosan can be recovered by adding an acid such as acetic acid to a medium containing chitin and chitosan to dissolve it, then treating it with an alkaline solution to neutralize it, separating the solid components obtained, discarding the supernatant, neutralizing the residue, and washing it with water. Chitin and chitosan can be purified from the fractions obtained as described above by appropriately combining separation techniques commonly used for isolating and purifying enzyme proteins, including methods that utilize differences in solubility (salting out, solvent precipitation, etc.), methods that utilize differences in molecular weight (dialysis, ultrafiltration, gel filtration, non-denaturing PAGE, SDS-PAGE, etc.), methods that utilize charges (ion exchange chromatography, hydroxylapatite chromatography, etc.), methods that utilize specific affinities (affinity chromatography, etc.), methods that utilize differences in hydrophobicity (reversed-phase high-performance liquid chromatography, etc.), and methods that utilize differences in isoelectric points (isoelectric focusing, etc.).
[0043] The present invention will be described in more detail in the following examples, but the present invention is not limited to these examples in any way. EXAMPLES
[0044] Test Example 1: Smi1 gene was functionally deleted Saccharomyces cerevisiae Chitosan production culture by 1. Plasmid and Strain Construction By artificial gene synthesis Smi1 A mutant form in which a stop codon has been inserted into the ORF of a gene smi1 A vector fragment was obtained by inverse PCR using the budding yeast genome integration type pGK405 as a template, and the mutant type was cloned using the Clontech In-fusion HD Cloning Kit (TaKaRa Inc.). smi1 By linking the fragment, mutant smi1 Genomic integration vector pGK405- smi1 was constructed. Similarly, the mutant crh1 Fragment (SEQ ID NO:2), mutant form pun1 Fragment (SEQ ID NO:3), mutant form cwp2 Fragment (SEQ ID NO: 4), mutant form gas1 Fragment (SEQ ID NO:5), mutant form crh2 Fragment (SEQ ID NO:6), mutant form fks1 The fragment (SEQ ID NO: 7) was obtained and ligated with pGK405 to give pGK405- crh1 , pGK405- pun1 , pGK405- cwp2 , pGK405- gas1 , pGK405- crh2 was constructed. The constructed pGK405- smi1 of S. cerevisiae The BY4741 strain was introduced and subjected to double crossover to identify the Smi1 Mutating the sequence smi1 In the same manner, the strains in the table below (strains with reduced expression levels) were constructed by introducing the constructed mutant protein expression vectors.
[0045] [Table 1]
[0046] Then, by artificial gene synthesis, Tdh3 the promoter region of a gene, Cda1 ORF of a gene, Tdh3 Terminator regions of genes, Pgk1 the promoter region of a gene, Cda2 ORF of a gene, Pgk1 The terminator region of the gene was linked to Cda1 - Cda2 An expression cassette fragment (SEQ ID NO: 8) was obtained. A vector fragment was obtained by inverse PCR using the 2 micron type high copy vector pGK425 as a template, Cda1 - Cda2 By ligating with the expression cassette fragment Cda1 - Cda2 Expression vector pGK425- Cda1 - Cda2 was constructed. The resulting pGK425- Cda1 - Cda2 was introduced into the aforementioned strain with reduced expression levels to construct the strains shown in the table below.
[0047] [Table 2]
[0048] SEQ ID NO: 1 Mutant smi1
[0049] SEQ ID NO:2 Mutant crh1
[0050] Sequence number 3, mutant pun1 ATGAGGAATTTTTTCACGTTATTTTTTGCAGCTATATTTTCGCTAGGAGCACTTATATTAGCCATTGTTGCATGCGCAGGATCAACGAAAAATTACAGTCCCATAAATAAAATTTACTGTGCAGAATTGGATCTGTCGCAGATGAAGGTATCGAACTAGTGCTCCCTTCTTTGAGTTCTGCTACGCTATCTTCGTTGGGCCTGCCCTCATATATAAATATAGGGCTTTGGTCGTACTGTACAGTGGACTCCTCGCATAACATCCAATCATGTTCTTCGCCTCACGGTATCCAGAATTTTAACCTATCGTCATTAGTGTATGACAATATCAACAACAATGAGGCTCTGGAGCTTATGGATTCCGTGGCCAGTGTTGTTTTGCCCGAAAAACTAAAAAGTAAAATGACATACTACAACAATTTGGTCAAGTGTATGTTCATTACCATTCTTATTGGTATTGTCTTGACCTTTGTGAATCTAGTGTTCAACGTATTGCGCTGGATCATCCACATAAGGCCGCTAACGTGGTTTGGTGCCTTTTTTTCATTTTTCGCCTTTGCCGCCCTATTAGTCAGTATAGGTTCGTGTTTGGGCACTTACTCATACATCAAATACATCCTAAAGCATAACTATAGTGATTACGGTATTTCAATGAGCATTGGTAGGAACTACCAGGGTTTGATGTGGGGGGCTGTCGTTGGAGCATTACTGAATTTCATTCTATGGTGTAGCGTGAGATCGAGGCCCACCGTCATCTATGCGAACGCTCCAATTGAGGAAAAACCATTGATTTGA
[0051] Sequence number 4, mutant cwp2 ATGCAATTCTCTACTGTCGCTTACTAGTTGCTTTCGTCGCTTTGGCTAACTTTGTTGCCGCTGAATCCGCTGCCGCCATTTCTCAAATCACTGACGGTCAAATCCAAGCTACTACCACTGCTACCACCGAAGCTACCACCACTGCTGCCCCATCTTCCACCGTTGAAACTGTTTCTCCATCCAGCACCGAAACTATCTCTCAACAAACTGAAAATGGTGCTGCTAAGGCCGCTGTCGGTATGGGTGCCGGTGCTCTAGCTGCTGCTGCTATGTTGTTATAA
[0052] SEQ ID NO: 5 Variant gas1
[0053] SEQ ID NO:6 Mutant crh2
[0054] SEQ ID NO: 7 Mutant fks1
[0055] SEQ ID NO:8 Cda1-Cda2 expression cassette
[0056] 2. Chitosan production culture Each strain was cultured for chitosan production. The composition of the medium used is shown in the table below.
[0057] [Table 3]
[0058] Each strain was inoculated into 3 mL of the above medium placed in a medium-sized test tube and cultured with shaking at 30°C and 200 rpm to obtain a preculture solution. The preculture solution was inoculated at 0.2% into 50 mL of the above medium placed in a 500 mL baffled flask and cultured with shaking at 30°C and 160 rpm. On the fifth day of cultivation, the culture medium was collected, acetic acid was added to a final concentration of 2%, and the mixture was mixed by inversion on a rotator for more than 3 hours to solubilize chitosan. The mixture was centrifuged to discard the bacterial debris, and the resulting chitosan solution was concentrated using a 3K ultrafiltration filter. 96% sulfuric acid was added to the concentrated solution to a final concentration of 72% (w / w) and mixed. After leaving it at room temperature for 3 hours, water was added and the mixture was heated at 100°C for an additional 4 hours. The resulting sulfuric acid hydrolyzate was cooled on ice and neutralized by adding a saturated aqueous solution of barium hydroxide. The neutralized solution was centrifuged to obtain the supernatant. The resulting neutralized solution was analyzed by HPLC, and the acid hydrolyzate of chitosan, GlcN, was quantified as the amount of chitosan produced. In the table below, lowercase letters and underlines (e.g. smi1 ) means that a mutation has been introduced into the gene to cause it to lose its function. pGK425 is the name of the plasmid DNA. Capital letters and underlines (e.g. CDA1 ) indicates that an entire gene has been introduced to add or enhance function.
[0059] [Table 4]
[0060] [Table 5]
[0061] Test Example 2: Examination of phosphorylated protein levels Example 3 (prepared in Test Example 1) gas1 crh2 crh1 smi1 / pGK425- CDA1 - CDA2 ) and Comparative Example 4 ( gas1 crh2 crh1 / pGK425- CDA1 - CDA2 ) to examine the changes in the phosphorylation levels of each peptide (Slt2, Rlm1, Crz1) due to Smi1 disruption. Each strain was cultured, and total protein was extracted from the cells. After pretreatment, phosphorylated proteins were concentrated and quantified by LC-MS. The results are shown in Table 6. When a protein was fragmented into multiple peptides during the analysis process, the phosphorylation level was measured for each peptide.
[0062] [Table 6]
[0063] Disruption of Smi1 (Smi1 function deficiency) increased the phosphorylation levels of Slt2 and Rlm1, confirming activation of the CWI pathway, and loss of Smi1 function increased the phosphorylation level of Crz1, confirming inactivation of the CN pathway. [Industrial Applicability]
[0064] According to the present invention, it is possible to produce chitin and chitosan using microorganisms. In particular, by converting glucose into chitosan through an enzymatic reaction within the cells and secreting and producing it, stable production with little environmental impact is possible.
Claims
1. 1. A modified microorganism that produces chitin, comprising: The microorganism is characterized in that, as a result of the modification, the cell-wall integrity pathway (CWI pathway) is activated and the calcineurin pathway (CN pathway) is inactivated, compared to an unmodified microorganism.
2. The microorganism according to claim 1, further comprising at least one functional deficiency of a cell wall synthesis gene.
3. The microorganism according to claim 1, further comprising at least one functional deficiency of a gene for maintaining cell wall integrity.
4. The microorganism according to claim 2 , further comprising at least one functional deficiency of a gene for maintaining cell wall integrity.
5. The microorganism according to claim 1 , wherein the modification is a functional deficiency of the Smi1 gene in the microorganism.
6. The microorganism according to claim 2, wherein the cell wall synthesis gene is selected from the group consisting of a chitin transglycosylase gene and a β-glucan synthase gene.
7. The microorganism according to claim 3 , wherein the cell wall integrity maintaining gene is selected from the group consisting of a cell wall protein gene and a membrane protein gene.
8. The microorganism of claim 4 , wherein the cell wall integrity maintaining gene is selected from the group consisting of a cell wall protein gene and a membrane protein gene.
9. The microorganism according to claim 1, which has been further modified so that chitin can be converted into chitosan intracellularly.
10. The microorganism according to claim 9 , wherein the modification capable of converting chitin into chitosan within the cell is achieved by introducing a chitin deacetylase gene.
11. The microorganism according to any one of claims 1 to 10, wherein the microorganism is a yeast.
12. The microorganism of claim 11 , wherein the yeast is Saccharomyces cerevisiae.
13. A method for producing chitin / chitosan using a microorganism capable of producing chitin, comprising the steps of: A method for producing chitin / chitosan, which includes modifying the microorganism so that the cell-wall integrity pathway (CWI pathway) is activated and the calcineurin pathway (CN pathway) is inactivated compared to an unmodified microorganism.
14. The method for production according to claim 13, further comprising functionally deleting at least one cell wall synthesis gene.
15. The method for production according to claim 13, further comprising functionally deleting at least one cell wall integrity maintaining gene.
16. The method for production according to claim 14, further comprising functionally deleting at least one cell wall integrity maintaining gene.
17. The method for production according to claim 13 , wherein the modification comprises rendering the Smi1 gene in the microorganism functionally non-functional.
18. The method according to claim 14, wherein the cell wall synthesis gene is selected from the group consisting of a chitin transglycosylase gene and a β-glucan synthase gene.
19. The method of claim 15, wherein the cell wall integrity maintaining gene is selected from the group consisting of a cell wall protein gene and a membrane protein gene.
20. The method of claim 16, wherein the cell wall integrity maintaining gene is selected from the group consisting of a cell wall protein gene and a membrane protein gene.
21. The method according to claim 13, further comprising modifying the cells so that chitin can be converted into chitosan within the cells.
22. The method according to claim 21, wherein the modification that enables the conversion of chitin to chitosan in the cells is achieved by the introduction of a chitin deacetylase gene.
23. The method according to any one of claims 13 to 22, wherein the microorganism is a yeast.
24. The method of claim 23, wherein the yeast is Saccharomyces cerevisiae.
25. The method according to claim 21, comprising culturing a microorganism in a medium containing a carbon source and allowing the microorganism to secrete chitin / chitosan into the medium.
26. The method of claim 25, wherein the carbon source is glucose.
Citation Information
Patent Citations
Production of cell surface layer substance by yeast protoplast
JP1996103271A
Cell wall derivative from biomass and its preparation method
JP2005529191A
KR1996/0023035
Metabolic engineering for enhanced production of chitin and chitosan in microorganisms
WO2004092391A2
Recombinant wine yeasts
WO2009144358A2
